Company intelligence / Profile preview

Paragon Bioservices

Baltimore, Maryland, United Statesbiologics.catalent.com ↗

Ownership: Private
Employees: ~380
Development stage: Commercial

Overview

Paragon Bioservices was an industry-leading CDMO specializing in viral vector development and GMP manufacturing services primarily supporting gene therapies using adeno-associated virus vectors. The company supported more than half of the top global gene therapy developers with projects ranging from preclinical through commercial stages. At acquisition by Catalent in May 2019 for $1.2 billion, it had recently opened a state-of-the-art commercial-scale facility near Baltimore-Washington International Airport capable of large-scale GMP production.

Therapeutic areas: OncologyRare DiseasesGastroenterologyInfectious Diseases
Modalities: Gene therapy (AAV vectors)Oncolytic virus therapyVaccine (next-generation vaccines)Biologic (therapeutic proteins)Cell therapy (including CAR-T cell therapy support)
Industry: Contract Manufacturing Organization

Partnerships

Supported more than half the top global gene therapy developers at time of acquisition; specific partnerships are confidential/client-based but included major pharma/biotech companies developing advanced biologics/gene therapies.

Beyond the preview

Go deeper on Paragon Bioservices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paragon Bioservices.

Explore the full profile